Pay in 4 interest-free payments of $6.79 Learn more
Ships within 48 hours · Estimated delivery Oct 6 - Oct 11
Prevalence and clinical impact of Met Y1253D-activating point mutation in radiotherapy-treated squamous cell cancer of the oropharynx
GHK-Cu is supplied in a lyophilized vial format for laboratory research workflows
Examined for involvement in angiogenesis and vascular function in experimental systems
In airway/alveolar epithelial cells treated with CSE and in smoke-exposed mouse models, these drugs can reduce lipid ROS accumulation, partially restore GPX4 function, and alleviate alveolar septal damage and inflammatory infiltration, thereby providing functional evidence supporting the causal role of ferroptosis in COPD structural damage and inflammation amplification (267)
Expert Rev Neurother 15(7):793802
